Article Text

Download PDFPDF
Amplification: management of multiple sclerosis (2 June 1986, p 41–2)


Readers have asked why we said that the continuing use of hyperbaric oxygen is not recommended. The reason is that the controlled trials of this treatment in the UK have not shown any clear benefit.1,2 Recent claims that titration of oxygen pressure for individual patients gives useful results for most patients,3 and that the treatment is bound to help patients suffering an acute attack,4 have not been tested in controlled trials.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.